Purpura
Showing 51 - 75 of 1,747
Thrombotic Thrombocytopenic Purpura, Acquired Trial in Beijing (Bortezomib Injection)
Not yet recruiting
- Thrombotic Thrombocytopenic Purpura, Acquired
- Bortezomib Injection
-
Beijing, (Select), ChinaPeking Union Medical College Hospital
Nov 22, 2021
Refractory Systemic Lupus Erythematosus, Lupus Nephritis, Immune Thrombocytopenia Trial in Peking (CNCT19 cell injection)
Enrolling by invitation
- Refractory Systemic Lupus Erythematosus
- +2 more
- CNCT19 cell injection
-
Peking, ChinaXiaofeng Zeng
Jul 3, 2023
Immune Thrombocytopenic Purpura Trial in Valhalla (rituxan)
Recruiting
- Immune Thrombocytopenic Purpura
-
Valhalla, New YorkNew York Medical College
Aug 4, 2021
Purpura, Thrombocytopenic, Idiopathic Trial in Germany, United Kingdom, United States (BIVV009 6.5 grams, BIVV009 7.5 grams)
Completed
- Purpura, Thrombocytopenic, Idiopathic
- BIVV009 6.5 grams
- BIVV009 7.5 grams
-
Georgetown, District of Columbia
- +4 more
Apr 22, 2022
Thrombotic Thrombocytopenic Purpura (TTP) Trial in Worldwide (BAX930, Standard of care)
Recruiting
- Thrombotic Thrombocytopenic Purpura (TTP)
- BAX930
- Standard of care
-
Atlanta, Georgia
- +29 more
May 4, 2022
Thrombotic Thrombocytopenic Purpura Trial in United States (rituximab)
Completed
- Thrombotic Thrombocytopenic Purpura
- rituximab
-
Atlanta, Georgia
- +3 more
Aug 13, 2021
The ConNeCT Study: Neurological Complications of TTP
Recruiting
- Thrombotic Thrombocytopenic Purpura
- Questionnaires (including PHQ-9, TYM and SF-36)
-
Liverpool, United KingdomRoyal Liverpool University Hospital
Aug 2, 2021
Crohn Disease, Ulcerative Colitis, Celiac Disease Trial in Hong Kong (Fecal Microbiota Transplantation)
Recruiting
- Crohn Disease
- +26 more
- Fecal Microbiota Transplantation
-
Hong Kong, Shatin, Hong KongThe Chinese University of Hong Kong
Feb 10, 2022
Primary Immune Thrombocytopenia Trial in Beijing (STSA-1301 subcutaneous injection, Placebo)
Recruiting
- Primary Immune Thrombocytopenia
- STSA-1301 subcutaneous injection
- Placebo
-
Beijing, Chaoyang District, ChinaBeijing Ditan Hospital,Capital Medical University
Nov 28, 2023
Activity and Safety of Fostamatinib in Consecutive Adult ITP
Not yet recruiting
- ITP - Immune Thrombocytopenia
- +2 more
- (no location specified)
Jan 12, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaChinese Academy of Medical Science and Blood Disease Hospital
Aug 9, 2023
ITP - Immune Thrombocytopenia Trial (hetrombopag 5mg po qd, High-dose Dexamethasone)
Not yet recruiting
- ITP - Immune Thrombocytopenia
- hetrombopag 5mg po qd
- High-dose Dexamethasone
- (no location specified)
Jul 5, 2023
Immune Thrombocytopenia, Pregnancy Related Trial (intravenous immunoglobulin plus low dose recombinant human thrombopoietin
Not yet recruiting
- Immune Thrombocytopenia
- Pregnancy Related
- intravenous immunoglobulin plus low dose recombinant human thrombopoietin (rhTPO)
- intravenous immunoglobulin
- (no location specified)
Dec 1, 2022
Idiopathic Thrombocytopenic Purpura Trial in Russian Federation (GNR-069, Nplate)
Recruiting
- Idiopathic Thrombocytopenic Purpura
- GNR-069
- Nplate
-
Irkutsk, Irkutsk Region, Russian Federation
- +17 more
Aug 3, 2022
Idiopathic Thrombocytopenic Purpura Trial in Cairo (Eltrombopag, conventional)
Completed
- Idiopathic Thrombocytopenic Purpura
-
Cairo, EgyptAinshams University , Faculty of medicine , Pediatric Hematology
Oct 26, 2021
Acquired Thrombotic Thrombocytopenic Purpura Trial in Worldwide (Caplacizumab, Standard of Care)
Completed
- Acquired Thrombotic Thrombocytopenic Purpura
- Caplacizumab
- Standard of Care
-
Saint Louis, Missouri
- +44 more
Mar 21, 2022
Immune Thrombocytopenia, Purpura, Thrombocytopenic Trial in Jinan (Atorvastatin 20mg, Atorvastatin 10mg, Dexamethasone)
Not yet recruiting
- Immune Thrombocytopenia
- Purpura, Thrombocytopenic
- Atorvastatin 20mg
- +2 more
-
Jinan, Shandong, ChinaQilu hospital, Shandong University
Aug 30, 2021
Primary Immune Thrombocytopenia (ITP) Trial (Ianalumab)
Not yet recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- (no location specified)
Jun 5, 2023
Thrombocytopenia, Immune, Heparin Induced Thrombocytopenia Trial (VLX-1005, Placebo)
Not yet recruiting
- Thrombocytopenia, Immune
- Heparin Induced Thrombocytopenia
- VLX-1005
- Placebo
- (no location specified)
Mar 24, 2023
Immune Thrombocytopenia, Treatment Trial in Tianjin (Obinutuzumab Injection [Gazyva])
Not yet recruiting
- Immune Thrombocytopenia
- Treatment
- Obinutuzumab Injection [Gazyva]
-
Tianjin, ChinaInstitute of Hematology and Blood Diseases Hospital, Chinese Aca
Oct 17, 2023
Immune Thrombocytopenia Trial (Daratumumab Injection)
Not yet recruiting
- Immune Thrombocytopenia
- Daratumumab Injection
- (no location specified)
Sep 28, 2022
Long-term Sequelae of Childhood Meningitis and Meningococcal
Recruiting
- Meningitis, Meningococcal
- Sequela
- sequela evaluation
-
Argenteuil, France
- +7 more
Aug 2, 2021
Primary Immune Thrombocytopenia (ITP) Trial in Singapore (Ianalumab, Placebo, Corticosteroids)
Recruiting
- Primary Immune Thrombocytopenia (ITP)
- Ianalumab
- +2 more
-
Singapore, SingaporeNovartis Investigative Site
Jan 17, 2023
ITP, Immune Thrombocytopenia Trial in Beijing (Baricitinib)
Recruiting
- ITP
- Immune Thrombocytopenia
-
Beijing, Beijing, ChinaPeking University Insititute of Hematology, Peking University Pe
Sep 27, 2022